MeiHua Holdings Group Co.,Ltd Stocks

CN¥ 10.93Last Updated 13.04.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

CN¥ 4.49B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 10.93
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

MeiHua Holdings Group Co.,Ltd provides amino acid nutrition and health solutions. Its products include food additives, including sodium glutamate, natamycin, disodium 5'-ribonucleotide, disodium inosinate, xanthan gum, pullulan, and trehalose; condiments, such as monosodium glutamate (MSG); amino acid for feed comprising valine, L-lysine sulphate and HCL, L-threonine, L-tryptophane, corn gluten meal for feedstuffs, corn husk powder, corn fiber feed, and boutique MSG residue. The company also provides pharmaceutical amino acids consisting of L-glutamine, L-leucine, L-isoleucine, L-valine, BCAA, L-proline, inosine, vernine, and adenosine; colloids; enteric, cellulose, gelatin, and pullulan capsules; and fertilizers, which include soil conditioners. MeiHua Holdings Group Co.,Ltd was founded in 2002 and is headquartered in Langfang, China.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks